Vanberra Signal

BiopTis

Curated by Signal

In vitro diagnostic assays for equine health research

Overview

BiopTis develops equine specific In Vitro Diagnostic kits, provides services in the field of inflammation, oxidative stress and mitochondrial function and conducts clinical trials to improve health and maintain athletic performance of horses.

Key facts

Founded
2008
Headquarters
Liege, Belgium

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Cloud-based data management tool and hardware for providers

    Health TechnologyZaventem, Belgium
  • Provider of speech recognition software for EHR documentation

    Health TechnologyAuderghem, Belgium
  • Digital compass for the psychotherapy treatment trajectory

    Health TechnologyLeuven, Belgium

About BiopTis

What does BiopTis do?

BiopTis develops equine specific In Vitro Diagnostic kits, provides services in the field of inflammation, oxidative stress and mitochondrial function and conducts clinical trials to improve health and maintain athletic performance of horses.

Where is BiopTis headquartered?

BiopTis is headquartered in Liege, Belgium.

When was BiopTis founded?

BiopTis was founded in 2008.

Which sector is BiopTis in?

BiopTis operates in Health Technology.

Who are BiopTis's competitors?

Companies similar to BiopTis include Perennity, Auditext, and QIT.